Kangpu Biopharmaceuticals, Ltd.
4 clinical trials · Sponsor
◉ Watch Kangpu Biopharmaceuticals, Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects (NCT04283097) | Kangpu Biopharmaceuticals, Ltd. | 2021-09-13 |
| Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE (NCT04643067) | Kangpu Biopharmaceuticals, Ltd. | 2021-06-03 |
| Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients (NCT03569280) | Kangpu Biopharmaceuticals, Ltd. | 2019-11-26 |
| Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy Subjects (NCT03949426) | Kangpu Biopharmaceuticals, Ltd. | 2019-05-01 |
Track Kangpu Biopharmaceuticals, Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.